DOI: 10.1055/s-00000133

Gastroenterologie up2date

References

Lorenzen S, Duyster J, Lersch C. et al.
Capecitabine plus docetaxel every three weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial. 
Brit J Cancer 2005; 92: 2129-2133  

Download Bibliographical Data

Search in:
Access: